论文部分内容阅读
将症状发作后4小时内入院的144例心肌梗塞患者随机分组,治疗组(73例)在3小时以内静注单股重组纤维蛋白溶酶原激活剂100毫克,对照组(71例)以同样的速度注入安慰剂。在这之前,两组都曾注入
One hundred and forty-four patients with myocardial infarction who were admitted to hospital within 4 hours after the onset of symptoms were randomly assigned. The treatment group (n = 73) received 100 mg of recombinant plasminogen activator within 3 hours, while the control group (n = 71) Infusion of placebo. Before that, both groups were injected